Dr. Felix Frueh
CEO,
R&D
Ariana Pharma
France
Biography
Dr. Felix Frueh: CEO, Intellos Health LLC Thought leader in personalized medicine with twenty years of R&D, management and policy experience. Co-Founder and CEO of Intellos Health LLC, a new diagnostic business. Prior, he was Chief Scientific Officer at Human Longevity, Inc. and Entrepreneur-in-Residence at Third Rock Ventures. Dr. Frueh was President of the Medco Research Institute, leading the PBM’s research initiatives in health economics and outcomes research. Prior to Medco, he was the first Associate Director for Genomics at the FDA, where he oversaw the development and implementation of policies around biomarker qualification and companion diagnostics. Dr. Frueh received his education at Stanford University and the University of Basel in Switzerland, where he graduated magna cum laude in biochemistry
Research Interest
personalized medicine development and implementation of policies around biomarker